COMMUNIQUÉS West-GlobeNewswire

MacroGenics Names Dr. Jay Siegel to its Board of Directors
15/11/2017
ROCKVILLE, MD, Nov. 15, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Allscripts to deliver anaesthesiology solution at the Royal Adelaide Hospital
15/11/2017
ADELAIDE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) has been appointed by South Australia Health to deliver its anaesthesia information management system (AIMS) at the Royal Adelaide [...]
Allscripts to deliver anesthesiology solution at the Royal Adelaide Hospital
15/11/2017
ADELAIDE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) has been appointed by South Australia Health to deliver its anesthesia information management system (AIMS) at the Royal Adelaide [...]
Spring Bank Pharmaceuticals Announces Positive Top-Line Results from the Second Cohort of Part A of the Phase 2 ACHIEVE Trial
15/11/2017
Low Dose of Inarigivir Soproxil (50mg) Monotherapy Demonstrates a Favorable Safety Profile and Significant Dose-Dependent Antiviral Activity, Meeting Both Primary Endpoints Conference Call Scheduled for Tomorrow, Nov. [...]
K2M Group Holdings, Inc. to Participate in the 29th Annual Piper Jaffray Healthcare Conference
15/11/2017
LEESBURG, Va., Nov. 15, 2017 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]
BioCanCell Announces Updated Results from the Phase 2 Clinical Trial of BC-819 and BCG in Patients with Bladder Cancer
15/11/2017
JERUSALEM, Nov. 15, 2017 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE: BICL ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat cancer, [...]
Adverum Biotechnologies to Present at Upcoming Conferences
15/11/2017
MENLO PARK, Calif., Nov. 15, 2017 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a leading gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced today that [...]
Nuvectra to Present at the 29th Annual Piper Jaffray Healthcare Conference
15/11/2017
PLANO, Texas, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief [...]
Articles of Association for Genmab A/S
15/11/2017
Genmab A/S has published its Articles of Association dated November 14, 2017. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm Contact: Rachel Curtis Gravesen, Senior Vice [...]
Safe Landing, Teen Substance Abuse Treatment Center, Opens in North Miami
15/11/2017
NORTH MIAMI, Fla., Nov. 15, 2017 (GLOBE NEWSWIRE) -- The substance abuse epidemic impacting all of the United States is devastating families, derailing promising futures, and threatening American communities. One of the [...]
Ultragenyx Announces FDA Approval of MEPSEVII™ (vestronidase alfa), the First Therapy for Progressive and Debilitating Rare Genetic Disease Mucopolysaccharidosis VII
15/11/2017
NOVATO, Calif., Nov. 15, 2017 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]
Sienna Announces November Dividend
15/11/2017
MARKHAM, Ontario, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) today announced a dividend of $0.075 per common share of the Company (each, a “Common Share”) for [...]
Sales of Olainfarm in October Shrink by 7%
15/11/2017
Olaine, 2017-11-15 16:57 CET (GLOBE NEWSWIRE) -- October 2017, consolidated sales Sales, thsnd. EUR Changes to October 2016 Share in total sales Russia 3 434 -18% 36% Latvia 2 754 18% 29% Ukraine 1 143 3% 12% Belarus [...]
American Health Council Recognizes Todd Heaton, MD, MPH as “America’s Best Doctor”
15/11/2017
NEW YORK, Nov. 15, 2017 (GLOBE NEWSWIRE) -- The American Health Council is proud to announce Pediatric Surgeon Todd Heaton, MD, MPH as “America’s Best Doctor” because of his outstanding patient care, academic prowess, [...]
Tempus Announces Latest Immunotherapy Project
15/11/2017
CHICAGO, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, along with Georgetown [...]
Scott VanderWel Joins PCI Synthesis as Business Development Manager
15/11/2017
NEWBURYPORT, Mass., Nov. 15, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. ( www.pcisynthesis.com ), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and [...]
HEALIOS Announces Enrollment of First Patient in Japan in TREASURE Study of MultiStem® Treatment for Ischemic Stroke
15/11/2017
CLEVELAND, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX ) announced today that its partner, HEALIOS K.K. (“Healios”), has enrolled the first patient in its study in Japan evaluating MultiStem ® cell [...]
Tabula Rasa HealthCare to Participate in the 29th Annual Piper Jaffray Healthcare Conference
15/11/2017
MOORESTOWN, N.J., Nov. 15, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC ), a healthcare technology company optimizing medication safety by deploying new medication risk mitigation digital [...]
Hemispherx Biopharma, Inc. CEO Interviewed on CEOLIVE.TV
15/11/2017
PHILADELPHIA, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), based in Philadelphia, focused on pharmaceuticals, today announced that Thomas K. Equels, M.S. J.D., Chief Executive [...]

Pages